Intellectual Property India Publishes Patent Application for 'Nintedanib And Nintedanib Combination Dry Powder Compositions And Uses' Filed by Avalyn Pharma Inc.

MUMBAI, India, March 7 -- Intellectual Property India has published a patent application (202417097958 A) filed by Avalyn Pharma Inc., Cambridge, U.S.A., on Dec. 11, 2024, for 'nintedanib and nintedanib combination dry powder compositions and uses.'

Inventor(s) include Surber, Mark William; and Pham, Stephen.

The application for the patent was published on March 7, under issue no. 10/2025.

According to the abstract released by the Intellectual Property India: "The invention includes dry powder nintedanib formulation for dispersion and inhalation administration including salts therof, indolinone derivative or salts thereof and in fixed dose combinations with carrier agents and other active ingredients. The aerosol delivery combination for...